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Abstract
Background:  Management of asthma can be complicated by both medical and psychiatric
conditions, such as gastroesophageal reflux, chronic sinusitis, and anxiety. When symptoms of
asthma are interpreted without regard to such conditions treatment may yield a suboptimal
outcome. For example, anxiety-associated dyspnea, tachypnea, and chest tightness can be
mistakenly interpreted as resulting from an exacerbation of asthma. Medical treatment directed
only for asthma may thus lead to overuse of asthma medications and increased hospitalizations.
Case Presentation: The described case illustrates how a systemic steroid-dependent patient
with asthma benefited from receiving care from a pediatric pulmonologist who also was well versed
in the diagnosis and treatment of anxiety. By using self-hypnosis, the patient was able to reduce her
dependence on bronchodilators. Following modification of her medical therapy under supervision
of the pulmonologist, and regular use of hypnosis, the patient ultimately was weaned off her
systemic steroid therapy.
Conclusions: This report emphasizes that anxiety must be considered as a comorbid condition in
the treatment of asthma. Self-hypnosis can be a useful skill in the treatment of a patient with anxiety
and asthma.
Background
It is well recognized that management of asthma can be
complicated by comorbid conditions, such as gastro-
esophageal reflux and chronic sinusitis. [1,2] When symp-
toms of asthma are interpreted without regard to such
conditions treatment may yield a suboptimal outcome.
[3,4] For example, anxiety might not be recognized as a
comorbid condition because its associated dyspnea, tach-
ypnea, and chest tightness can be mistakenly interpreted
as resulting from an exacerbation of asthma. [5] Medical
treatment directed only for asthma in a patient who also
has anxiety may lead to overuse of asthma medications
and increased hospitalizations. [6] Even when anxiety is
recognized, its treatment rarely is undertaken by the
health care provider who primarily manages the patient's
asthma. Instead, patients sometimes are referred to a men-
tal health professional for management of anxiety. In
other circumstances, the anxiety is recognized, but no spe-
cific treatment is offered.
The following case report illustrates how a systemic ster-
oid-dependent patient with asthma benefits from receiv-
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ing care from a pediatric pulmonologist who also is well
versed in the diagnosis and treatment of anxiety. This
example demonstrates a self-hypnosis approach for help-
ing patients with anxiety. This technique can be mastered
relatively easily by most health care providers.
Case Presentation
The patient was diagnosed with asthma at approximately
one year of age when she presented with coughing,
wheezing, and retractions. Use of p.r.n. albuterol by neb-
ulization relieved these symptoms. At two years of age,
she developed a severe exacerbation for which she
required admission to the Pediatric Intensive Care Unit.
From that time, with the exception of a six month period
between the ages of 5 and 6 years, she required systemic
steroid therapy to control her symptoms, until her presen-
tation to the Pediatric Pulmonary Center at the age of 12.
During this period, she required 6 admissions to the
intensive care unit, and 15 hospitalizations and emer-
gency department visits for asthma exacerbations.
Her mother became aware of the link between the
patient's high level of anxiety and asthma exacerbations
when the patient was in the Intensive Care Unit at the age
of 10. During that hospitalization, the patient became agi-
tated by discomforts such as the temperature of the food,
if chest physiotherapy was not performed to her satisfac-
tion, or if she did not receive her therapies "quickly
enough." When she was agitated, her muscles tensed, she
breathed deeply, cried loudly, and was inconsolable. She
could not verbalize her specific concerns but sometimes
yelled, "You're not doing anything for me." She was
referred for psychological counseling at that time, but
after 10 sessions the family felt that the visits were ineffec-
tive and discontinued them.
Triggers of the patient's episodes of respiratory distress
included decreasing her dose of systemic steroid, viral
upper respiratory infections, exposure to cold air, exercise,
and strong emotions. She stated that she developed
"upper lobe wheezing", with fast and deep breathing
when she became frustrated by social situations, such as
disagreements with her family or friends. She also stated
that these symptoms were different from her "lower lobe
wheezing" that she reported as being her "usual" asthma
symptom. She added that often she became anxious when
her asthma was triggered, and then she would breath
deeply and hyperventilate.
Her chronic therapies at the time of presentation to our
Center included: Prednisone (15 mg per day), leval-
buterol (0.63 mg, by nebulization, four times daily, and
p.r.n.); albuterol MDI (two puffs prior to gym); budeso-
nide (three puffs BID); and ipratropium bromide (0.5 mg,
by nebulization, p.r.n.) She used her p.r.n. medications
approximately every other day for dyspnea.
When she was 5 years old, skin-scratch testing revealed
that she was allergic to cats. A sweat chloride test was nor-
mal on two occasions. A bronchoscopy and ciliary biopsy
were normal. An immunological workup revealed an IgA
deficiency, but monthly gamma globulin therapy for nine
months, when she was 10 years old, was not associated
with an improvement in her symptoms. A 24-hour pH
probe study, at 11 years of age, revealed only mild gastro-
esophageal reflux, and therapy with cisapride for five
months was not associated with an improvement in her
symptoms.
The patient lived with her parents and two brothers in a
single-family house. There were no smokers in the home.
She was in the seventh grade. She missed "a lot" of school
because of her illnesses, and as a result she had some aca-
demic difficulties.
Her physical examination revealed a cushingoid appear-
ance, without distress. Her height was 138.1 cm (at the
3rd percentile for age), and her weight was 53.7 kg (90th
percentile for age). Her respiratory rate was 16 breaths/
min. The lung examination revealed slight expiratory
wheezing in the upper airway, which was transmitted to
her lower airways. There was good air movement through-
out. Otherwise, the examination was unremarkable.
Pulmonary function testing revealed normal expiratory
lung flows (forced vital capacity = 119% of predicted for
height and age, forced expiratory volume in one second =
106%, and forced mid-expiratory flow rate = 94%). Her
inspiratory loop was blunted, consistent with an upper
airway problem. Review of her pulmonary function tests
from the six years prior to her presentation revealed
mostly normal tests. On a few occasions, she had
decreased expiratory lung flows, which improved follow-
ing bronchodilator administration.
The initial assessment at our Center was that the patient
had asthma, given the improvement of her symptoms
with bronchodilator and systemic steroid therapies. How-
ever, it was suspected that an upper airway problem had
been playing a role in her presentation, given her report of
an "upper airway wheeze" in association with strong emo-
tions, her upper airway expiratory wheezing on physical
examination, and the blunting of the inspiratory loop
during the pulmonary function testing.
We discussed with the patient that given her severe
asthma, it would not be surprising if she became anxious
when she developed shortness of breath. The idea was
introduced that such anxiety might have led to develop-BMC Pediatrics 2003, 3 http://www.biomedcentral.com/1471-2431/3/7
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ment of symptoms for which asthma medications might
not have been helpful, including vocal cord dysfunction
that would account for her upper airway problem. No fur-
ther testing was performed in order to confirm a diagnosis
of vocal cord dysfunction. The patient's anxiety was not
assessed formally.
The patient accepted the opportunity to be taught self-
hypnosis to control her respiratory symptoms. Instruction
was provided over two weeks in two 45-minute sessions
by her pediatric pulmonologist who had received training
in hypnosis through three 20-hour workshops.
In the first session the patient was taught to hypnotize her-
self by imagining that she was walking from a beach
house towards the waterfront. She imagined herself lying
down and relaxing. She was instructed that she could
allow her body to relax whenever she touched her index
finger to her thumb ("finger relaxation technique"). On
the physical examination following hypnosis, her expira-
tory wheezing had diminished greatly. She was congratu-
lated upon her outstanding hypnotic abilities. She was
encouraged to practice hypnosis on a nightly basis, and to
apply her "finger relaxation technique" several times a
day. Within two weeks of daily utilization of self-hypno-
sis, she reported that she was able to use hypnosis instead
of nebulized levalbuterol approximately half the time.
In the second instruction session the patient was shown
how to develop imagery within hypnosis of a "tight air-
way that opens up" in order to help relieve airway obstruc-
tion. She was encouraged to utilize hypnosis as much as
she thought was helpful to her. Thereafter, during the
patient's follow-up visits for asthma management, the
pulmonologist inquired whether she was using hypnosis.
The patient was encouraged to continue its use, but was
not provided with further instruction regarding how to
use hypnosis. The follow-up visits occurred on a monthly
basis as the patient's asthma therapy was weaned, and
every 2–3 months thereafter.
After three months, she was able to wean herself com-
pletely off levalbuterol, which she had been using more
than four times a day. She explained that she found the
use of hypnosis to be as helpful as levalbuterol in treating
her shortness of breath. Further, she reported that her
bouts of shortness of breath were much less frequent than
prior to the use of hypnosis.
Once her regular use of levalbuterol was discontinued, she
began a slow wean off her systemic steroid therapy. Three
months into the steroid wean, when she was receiving
hydrocortisone (10 mg per day), she required hospitaliza-
tion for dyspnea that was only partially relieved with the
use of nebulized levalbuterol, oral prednisone (1 mg/kg/
day), and hypnosis. As she appeared very anxious, on the
fourth day of the hospitalization, she was prescribed a sin-
gle dose of clonazepam. She asked to go home on the fol-
lowing day.
Two weeks after this hospitalization her steroid weaning
schedule was resumed. She was hospitalized again nine
months into the steroid wean, after an exposure to ciga-
rette smoke at a relative's house. At the same time, her
mother was in the hospital with complications as a result
of a hysterectomy. Two weeks after discharge, her chronic
systemic steroid therapy was discontinued. Her medica-
tion regimen at the end of the weaning process was: fluti-
casone (110 mg, 2 puffs twice a day); salmeterol (2 puffs
twice a day); theophylline (300 mg, PO, twice a day);
budesonide nasal spray (2 squirts into each nostril per
day); and levalbuterol (0.63 mg, by nebulization, p.r.n.),
which she utilized once a month in treatment of shortness
of breath.
She was well for the subsequent year with the exception of
three asthma exacerbations induced by upper respiratory
infections, for which she required short courses of oral
prednisone. Over the year her height increased to 150 cm
(up to the 10th percentile for age), while her weight
increased to 66.7 kg (thereby remaining at the 90th per-
centile). She continued to use self-hypnosis on an almost
daily basis to decrease a sensation of dyspnea, relax,
reduce her frustrations, fall asleep, and improve her
school performance.
Discussion
Indicators in this patient's presentation that she might
respond to use of hypnosis include her lack of complete
response to medical therapy, report of dyspnea despite
normal lung function, [7] symptoms and signs suggestive
of upper airway involvement, and report that strong emo-
tions and anxiety triggered some of her respiratory symp-
toms.
The patient wanted to learn how to use hypnosis to con-
trol her anxiety. [8] She improved greatly following self-
hypnosis instruction, as she was weaned off chronic sys-
temic steroid therapy and frequent daily use of a neb-
ulized bronchodilator. Thus, this example emphasizes
that anxiety must be considered as a comorbid condition
in the treatment of asthma.
Children's report of anxiety has been shown not to be cor-
related with the severity of their asthma. [9] Thus, the pos-
sibility of anxiety as a cause of respiratory symptoms
should not be restricted only to patients with severe
asthma. Further, as symptoms of anxiety (e.g., dyspnea
and chest tightness) may be difficult to differentiate from
those of asthma, self-hypnosis might be offered as therapyBMC Pediatrics 2003, 3 http://www.biomedcentral.com/1471-2431/3/7
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for any interested patient with asthma who does not
respond easily to medical therapy. While formal assess-
ment of anxiety is not necessary prior to introduction of
self-hypnosis therapy, interested clinicians might utilize
anxiety inventories with both patients and their parents in
order to help assess the efficacy of therapy. [9,10]
While some anxiety is useful in motivating patients to
avoid asthma triggers, and rapidly assess and respond to
respiratory symptoms, excessive anxiety has been shown
to adversely affect management of asthma. [5] For exam-
ple, patients who hyperventilate during a panic attack, can
develop increased bronchospasm as a result of increased
inhalation of cold and dry air. [6] Also, patients who have
a high level of anxiety tend to perceive their degree of air-
way obstruction inaccurately, which leads to inappropri-
ate use of asthma medications as well as health care
resources. [5]
The anxiety reduction achieved with hypnosis by the
patient may have promoted an improvement in her sub-
jective assessment of her respiratory status. [11] Such an
improvement can allow patients to reduce their percep-
tion of dyspnea and thereby decrease their reliance on
bronchodilator therapy.
Another potential benefit of hypnosis facilitated stress
reduction for patients with asthma is its effect on the
body's immune function. [12] For example, psychological
stress has been shown to cause a shift in the cytokine type-
1/type-2 balance toward a predominant type-2 response
that is characteristic of asthma. [13] It remains to be stud-
ied whether such a shift and other stress induced changes
in the immune system predispose patients to developing
or worsening asthma, or if anxiety reduction alters the
immune response sufficiently to decrease patients' asthma
risk.
In addition to instruction in self-hypnosis or other relaxa-
tion techniques, [14] the anxiety of patients with asthma
can be improved by providing them with information
regarding the prognosis of their disease, as well as training
in accurate assessment of their triggers and degree of air-
way obstruction. [5] Thus, the patient in this report also
may have improved as a result of her close medical super-
vision.
The patient's improvement may in part have been the
result of the efficacy of hypnosis in treating vocal cord dys-
function. [15] However, a definitive diagnosis of vocal
cord dysfunction was not made in this case, as the patient
did not undergo a laryngoscopic examination of her vocal
cords while she was symptomatic. [16] Nevertheless, as
may have occurred in this case, self-hypnosis has been
shown to help resolve symptoms suggestive of vocal cord
dysfunction even in the absence of a definitive diagnosis.
[7]
The ability of a single care provider to manage both the
patient's medical and psychological needs appeared to
facilitate her therapy. However, some medical providers
may not have the background to manage anxiety without
collaboration with an individual trained in psychology or
psychiatry.
Clinicians interested in learning how to use hypnosis
within their medical practice should enroll in training
workshops, as hypnosis is learned best through exposure
to a variety of educational experiences, including didactic
presentations, demonstrations, modeling by different
hypnotherapists, and small group practice sessions. [17]
Such workshops are administered by the American Society
of Clinical Hypnosis, the Society for Clinical and Experi-
mental Hypnosis, and the Society for Developmental and
Behavioral Pediatrics. Clinicians can expect that following
participation in one or two 20-hour workshops that they
will have sufficient knowledge of hypnosis to be able to
apply it in several clinical situations.
Conclusions
Anxiety must be considered as a comorbid condition in
the treatment of asthma. Treatment of anxiety with self-
hypnosis or other measures is essential for the improve-
ment in the symptoms of some patients.
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